Tempus AI

American health technology company

HIRING · 1 OPEN AI

About

Build, maintain and scale data pipelines and models that power analytics, reporting, and self-service exploration.
Collaborate with BI engineers, product managers, and engineering teams to translate business needs into reliable data solutions.
Support data governance, including data quality monitoring and audits.
Contribute to the evolution of the BI data platform by applying best practices in data modeling, orchestration, and governance.
Investigate and resolve complex data issues in par...

Tempus AI

About

Updates & Highlights

Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI?

Caitong International Asset Management Co. Ltd Acquires 27,022 Shares of Tempus AI, Inc. $TEM

Tempus AI (TEM) Stock Could Be 22.9% Undervalued After ECG AF Validation

Recent Openings

Data Scientist II, Real World Evidence (RWE), Pharma R&D

All Jobs

Data Scientist II, Real World Evidence (RWE), Pharma R&D

Culture & Mission

Benefits & Perks

Equity/Stock Options

Health Insurance

Remote Work

Learning Budget

Competitive Salary

Generous PTO

Tech Stack

Core Values

Innovation

Collaboration

Excellence

Impact

Office Locations

Team

Are you on the team at Tempus AI?

News & Press

Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI?

Caitong International Asset Management Co. Ltd Acquires 27,022 Shares of Tempus AI, Inc. $TEM

Tempus AI (TEM) Stock Could Be 22.9% Undervalued After ECG AF Validation

Tempus AI, Inc. $TEM Shares Acquired by Virtu Financial LLC

Should You Retain Tempus AI Stock In Your Portfolio Now?

Tempus AI Stock (TEM) Opinions on Market Momentum

Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 39% Potential Upside Amidst Cutting-Edge Healthcare Innovations

Entropy Technologies LP Purchases New Holdings in Tempus AI, Inc. $TEM

When consent is no longer enough: genetic data and the Tempus AI case | by Raffaella Aghemo | Jun, 2026

New FDA Clearances for Genomics and Cardiac AI Could Be A Game Changer For Tempus AI (TEM)

Tangible book value per share of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI

Kelli Teno-Manalli Joins Tempus AI as Vice President, Head of Communications

Tempus AI (TEM) Stock After 23% Year-To-Date Decline Is Opportunity Emerging

Tempus AI expands cancer platform with launch of ArteraAI prostate test for metastatic patients

Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility?

Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility?

Tempus AI (TEM) Achieves Major Milestone with ECG Software Validation

Tempus AI (TEM) Achieves Major Milestone with ECG Software Validation

Tempus AI study validates heart rhythm prediction software